Zenflow, a South San Francisco, CA-based urologic medical device company, received a $5 million credit facility.
Square 1 Bank, a division of Pacific Western Bank, provided the debt financing.
The proceeds from the facility will support short-term and long-term growth initiatives.
Founded in 2014 by Nick Damiano, chief executive officer, and Shreya Mehta, Zenflow has developed the Spring® System, which allows patients experiencing benign prostatic hyperplasia (BPH) symptoms to undergo treatment in a simple procedure in an urologist’s office.
The Spring Implant, composed of super elastic shape-memory material, is deployed through a small, flexible catheter which can allow for a less invasive and less painful treatment.
It is currently undergoing clinical trials with leading global urologists and is available for investigational use only in select countries.
The company is backed by F-Prime Capital Partners, Invus Opportunities, Medical Technology Venture Partners, Y Combinator and the Stanford-StartX Fund.